Gentile Luana, Paolucci Matteo, Sessagesimi Elisa, Stagni Silvia, Caracciolo Nicoletta, Falcou Anne, Migliaccio Ludovica, Urbinati Giacomo, Forlivesi Stefano, Gentile Mauro, Cirelli Carlo, Di Ruzza Alberto, De Michele Manuela, Simonetti Luigi, Toni Danilo, Zini Andrea
IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Neurologia e Rete Stroke Metropolitana, Ospedale Maggiore, Bologna.
IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Neurologia e Rete Stroke Metropolitana, Ospedale Maggiore, Bologna.
J Neurol Sci. 2025 Aug 15;475:123576. doi: 10.1016/j.jns.2025.123576. Epub 2025 Jun 7.
International guidelines recommend only non-contrast CT (NCCT) for eligible acute ischemic stroke (AIS) patients receiving intravenous thrombolysis (IVT) in the early time window. We aim to assess the potential role of advanced neuroimaging in predicting radiological and clinical outcomes in AIS patients treated with IVT within 4.5 h of stroke onset.
Between July 2021 and August 2022, 262 AIS patients within 4.5 h underwent multimodal CT protocol (NCCT, CT-perfusion using RAPID software, multiphasic CT-Angiography). Demographic, clinical, and neuroradiological data, including CT-perfusion parameters were collected. Final infarct volume (FIV) and 3-month clinical outcomes using modified Rankin Scale (mRS) were assessed.
Patients with unfavourable 3-month outcome (mRS 3-6) were older, had higher baseline National Institutes of health Stroke Scale (NIHSS), a longer onset-to-needle time and a higher percentage of Baseline Alberta stroke programme early CT score (ASPECTS) ≤9. All perfusional parameters were notably more impaired in patients with 3-month unfavourable outcome. Patients with 3-month mRS 3-6 had a larger FIV at follow-up (p < 0.001). In multivariable binomial logistic regression model ischemic core as relative Cerebral Blood Flow (rCBF) < 30 % (p < 0.001), baseline NIHSS (p = 0.020) and TICI 0-2a (p = 0.005) independently predicted FIV > 10 ml. Age (p < 0.001), baseline NIHSS (p = 0.026), onset to needle time (p = 0.004) and rCBF<30 % (p = 0.005) independently predicted 3-month mRS 0-2. In multivariable ordinal logistic regression model rCBF<30 % was an independent predictor of 3-month mRS 3-6 (OR 1.04, p = 0.001).
In the early time window for IVT, the rCBF<30 % as ischemic core is a useful early predictor of FIV and 3-month clinical outcome.
国际指南建议,对于在早期时间窗内接受静脉溶栓(IVT)的符合条件的急性缺血性卒中(AIS)患者,仅进行非增强CT(NCCT)检查。我们旨在评估高级神经影像学在预测卒中发作4.5小时内接受IVT治疗的AIS患者的影像学和临床结局方面的潜在作用。
在2021年7月至2022年8月期间,262例发病4.5小时内的AIS患者接受了多模态CT检查(NCCT、使用RAPID软件的CT灌注、多期CT血管造影)。收集了人口统计学、临床和神经放射学数据,包括CT灌注参数。评估最终梗死体积(FIV)和使用改良Rankin量表(mRS)评估的3个月临床结局。
3个月结局不良(mRS 3-6)的患者年龄更大,基线美国国立卫生研究院卒中量表(NIHSS)更高,从发病到穿刺时间更长,基线阿尔伯塔卒中项目早期CT评分(ASPECTS)≤9的百分比更高。所有灌注参数在3个月结局不良的患者中受损更为明显。3个月mRS 3-6的患者在随访时FIV更大(p<0.001)。在多变量二项逻辑回归模型中,缺血核心即相对脑血流量(rCBF)<30%(p<0.001)、基线NIHSS(p=0.020)和脑梗死溶栓分级(TICI)0-2a(p=0.005)独立预测FIV>10ml。年龄(p<0.001)、基线NIHSS(p=0.026)、发病到穿刺时间(p=0.004)和rCBF<30%(p=0.005)独立预测3个月mRS 0-2。在多变量有序逻辑回归模型中,rCBF<30%是3个月mRS 3-6的独立预测因素(OR 1.04,p=0.001)。
在IVT的早期时间窗内,rCBF<30%作为缺血核心是FIV和3个月临床结局的有用早期预测指标。